Close

People

Jonathan Trinh maintains a cross-disciplinary, FDA regulatory practice.  Jonathan advises life sciences companies with navigating pre- and post-market regulatory challenges throughout their products’ lifecycles.  Specifically, Jonathan guides pharmaceutical, biotech, medical device, and cosmetics clients through applicable FDA laws and regulations, enabling them to commercialize and promote their products in the market.  He extends his subject matter expertise to support corporate teams on due diligence for contemplated M&A transactions and licensing agreements, white collar defense teams on internal and government investigations, and trial teams with litigation involving FDA-regulated products and entities.

Among his regulatory experience, Jonathan has served on a pharmaceutical client's MLR Review Committee, where he helped develop commercial strategies for launching a first-in-class rare disease drug product. 

Jonathan is a champion for diversity and inclusion, mentorship, and pro bono initiatives.  Jonathan actively participates in K&S's Diverse Retreat Planning Committee, K&S's Asian American and LGBTQ+ Affinity Groups, and bar associations and non-profit organizations committed to the professional development of diverse lawyers.  He represents K&S at diversity conferences and on-campus recruiting events to recruit rising leaders in the legal profession.  He also maintains an active pro bono practice dedicated to helping undocumented individuals pursue a legal pathway in the United States. 

Jonathan graduated from the George Washington University Law School with a concentration in health law.  There, he served as Editor-in-Chief of the Federal Circuit Bar Journal and authored a published note analyzing the ramifications of the Biologics Price Competition and Innovation Act’s “patent dance” on reference product sponsors. 

Full Bio

Credentials

J.D., George Washington University Law School

B.A. International Studies and Political Science, University of California, Berkeley, with honors

District of Columbia

Intern, Judge Rudolph Contreras, U.S. District Court for the District of Columbia

American Health Law Association

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Close

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Close

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Credentials

J.D., George Washington University Law School

B.A. International Studies and Political Science, University of California, Berkeley, with honors

District of Columbia

Intern, Judge Rudolph Contreras, U.S. District Court for the District of Columbia

American Health Law Association